SCHEMBL10175801

SCHEMBL10175801

COc1cncc(-c2nc3cc(F)c(F)cc3n2C2CC2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 20/20 1.00
CYP11B2 P19099 20/20 1.00
CYP19A1 P11511 2/20 0.72
ADRA2B P18089 1/20 0.72
CYP3A4 P08684 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17896637 0.91 CYP11B1 (0.83) CYP11B1CYP11B2CYP19A1ADRA2BCYP3A4
SCHEMBL17896727 0.88 CYP11B2 (0.78) CYP11B1CYP11B2CYP19A1ADRA2BCYP3A4
SCHEMBL10175434 0.86 CYP11B2 (0.76) CYP11B1CYP11B2CYP19A1ADRA2B
SCHEMBL17896662 0.86 CYP11B2 (0.75) CYP11B1CYP11B2CYP19A1ADRA2B
SCHEMBL20355224 0.85 CYP11B2 (0.79) CYP11B1CYP11B2CYP19A1ADRA2BCYP3A4
SCHEMBL459353 0.84 CYP11B2 (1.00) CYP11B1CYP11B2CYP19A1ADRA2BCYP3A4
SCHEMBL432286 0.83 CYP11B2 (0.76) CYP11B1CYP11B2CYP19A1ADRA2BCYP3A4
SCHEMBL17896678 0.81 CYP11B2 (0.77) CYP11B1CYP11B2CYP19A1ADRA2BCYP3A4
SCHEMBL17896655 0.81 CYP11B2 (0.69) CYP11B1CYP11B2CYP19A1ADRA2B
SCHEMBL17896676 0.81 CYP11B1 (0.68) CYP11B1CYP11B2CYP19A1ADRA2BCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9382226-B2 Aldosterone synthase inhibitors MERCK SHARP & DOHME CORP. (US) 2016-07-05 US disclosed
US-9382226-B2 Aldosterone synthase inhibitors MERCK SHARP & DOHME CORP. (US) 2016-07-05 US disclosed
WO-2012012478-A1 ALDOSTERONE SYNTHASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2012-01-26 WO disclosed